Genmab to Expand Oncology Business with $1.8 Billion ProfoundBio Acquisition
- April 05, 2024
Copenhagen, Denmark-based Genmab A/S will acquire oncology-focused biotechnology firm Profound Bio in a deal valued at $1.8 billion, the companies announced April 1.
ARTICLE TAGS
You must be logged in to access this content.